PEPTIDE ACCESS UPDATE · NOVEMBER 2026
Hearing more about peptides and wondering what the news means for you? HerScripts explains the six-peptide compounding update, the role of a licensed clinician, and the compounding pharmacy pathway planned for our online launch.
HHS has published an interim enforcement-discretion policy addressing conditional 503A compounding of six peptides. The Federal Register describes it as a draft. This is not FDA approval, and it does not establish that these treatments are safe or effective.
BPC-157 · TB-500 · Epitalon · MOTS-c · KPV · Semax
The policy is limited to specified peptide forms and administration routes. It requires patient-specific prescriptions, qualifying sourcing and testing, and other safeguards. Its single-active-ingredient condition does not cover blends of these peptides.
Compounded drugs are not FDA-approved. The policy may change as evidence and rulemaking develop.
A headline cannot tell you which treatment is appropriate for your symptoms. Discuss your medical history, medicines, goals, available evidence, risks and alternatives with a licensed clinician. These six substances should not be presented as established treatments for menopause, weight changes, sleep or other concerns simply because they appear in the policy.
Clinical assessment comes first. If a clinician considers a prescription appropriate, our compounding pharmacy pathway supports the next step. The prescribed formulation, state eligibility, costs and follow-up will be reviewed for each patient. A prescription or treatment is never guaranteed.
HerScripts has compounding pharmacy arrangements in place and plans to offer access to these six peptides when online enrollment launches. We are completing the patient access setup. Treatment will depend on clinical assessment, an appropriate prescription, state eligibility and applicable compounding requirements. Online enrollment is coming soon.
Federal Register notice · HHS policy and appendices
How HerScripts works · Explore care · Questions and answers
Information checked November 1, 2026.